The Steering Committee

Iron Resource Steering Committee

The refreshed Iron Resource website is a non-promotional, educational online resource which offers healthcare professionals, from a host of different therapeutic areas, the current and topical information they need to understand and manage iron deficiency effectively.

The development of the website content is guided and overseen by the Iron Resource Steering Committee, a group of respected experts in iron therapy who play an integral role in the management and growth of the website. By submitting opinion pieces and participating in interviews and advisory boards, the Steering Committee influence the evolution of the website through strategic planning – and work with the Iron Resource Secretariat to define editorial policy and content.

Please find details below regarding the Iron Resource Steering Committee:

Satish Keshav

Satish Keshav (Co-chair)
John Radcliffe Hospital, Oxford, United Kingdom

Satish Keshav is Consultant Physician in Gastroenterology and Honorary Senior Lecturer, specialising in inflammatory bowel disease, at the John Radcliffe Hospital, Oxford, United Kingdom.

Dr Keshav's research encompasses investigation of gastrointestinal immunity and inflammation as well as clinical studies and trials. His main interest is in understanding the mechanisms of organ-specific immunity and inflammation in the gastrointestinal tract. In particular, Dr Keshav is interested in determining the role of specialised epithelial cells, which maintain host defence and mediate between extrinsic microorganisms and the innate and adaptive immune systems. He also has an interest in, and has presented widely on, iron deficiency and anaemia in the context of gastrointestinal medicine.

Patrice Cacoub

Patrice Cacoub
Head of the Department of Internal Medicine, La Pitié-Salpêtrière Hospital, Paris, France

Patrice Cacoub is Professor of Internal Medicine at the Pierre and Marie Curie University and Head of the Department of Internal Medicine, La Pitié-Salpêtrière Hospital, Paris, France.

During his career, Professor Cacoub has conducted research on autoimmune diseases, hepatitis C (HCV) and B (HBV) virus, human immunodeficiency virus (HIV), peripheral neuropathies, anaemia and vascular medicine. He has also published on the importance of iron management in internal medicine, and has authored more than 550 research publications, 52 books and 120 Continuing Medical Education publications in these fields.

Professor Cacoub has been involved in the development of a number of national and international guidelines and clinical trials. He has also been involved in initiatives to improve clinical care, particularly in HCV treatment, autoimmune and autoinflammatory diseases, co-infection with HCV and HIV, and peripheral arterial disease.

Stefan Anker

Stefan Anker
University Medical Centre Göttingen (UMG) in Göttingen, Germany

Stefan Anker is Professor of Innovative Clinical Trials with a focus on Cardiology and Cachexia Research at the University Medical Centre Göttingen (UMG) in Göttingen, Germany.

Professor Anker’s main research activity is in clinical trials, in particular those on the pathophysiology of acute and chronic heart failure. His research interests also include the pathophysiology of symptom generation and cardiac dysfunction in cancer, biomarker research in acute and chronic heart failure, sarcopaenia, and anaemia/iron deficiency in heart failure.

Professor Anker serves as a councillor on the board of the European Society of Cardiology (ESC). He is also a member and past President of the board of the Heart Failure Association (HFA) of the ESC, and is the founding President of the International Society on Sarcopenia, Cachexia and Wasting Disorders. He is founding Editor-in-Chief of two journals: ESC Heart Failure and the Journal of Cachexia, Sarcopenia and Muscle. Professor Anker also serves on the editorial boards of four scientific journals, including the European Heart Journal, the European Journal of Heart Failure and the International Journal of Cardiology. He also serves as a member of a number of international clinical trial steering committees, data and safety monitoring boards and endpoint committees of clinical trials, for several of which he is the Chair. Professor Anker is the author of more than 500 original papers, reviews and editorials, with more than 29,000 citations.

Christian Breymann

Christian Breymann
Professor of Obstetrics and Gynaecology at the University of Zurich, Switzerland

Christian Breymann is Professor of Obstetrics and Gynaecology at the University of Zurich, Switzerland. He received his clinical training at the Munich University of Technology, Rechts der Isar Hospital, Germany, and went on to train in gynaecology and obstetrics at the University of Zurich.

Professor Breymann’s main areas of research are in haematological diseases in obstetrics, iron metabolism, recombinant erythropoietin in gynaecology and obstetrics, physiology of erythropoiesis in mother and foetus, and the diagnosis and treatment of anaemia. He serves as a Research Group Leader with Zentrum für Klinische Forschung (ZKF) (Centre for Clinical Research) in obstetrics research for foetomaternal haematology. Professor Breymann is a member of the Editorial Board of Transfusion Alternatives in Transfusion Medicine and of many societies, including the Swiss Obstetrics and Gynaecology Society and the Network on Advancements on Transfusion Alternatives.

Iain Macdougall

Iain Macdougall
Clinical Nephrology at King's College London, United Kingdom

Iain Macdougall is Consultant Nephrologist and Professor of Clinical Nephrology at King's College London, United Kingdom. His subspecialty interest is in anaemia associated with chronic kidney disease, and he has published widely in the field. He is also the Research and Development Lead for the Renal Department at King's, and the South London Renal Comprehensive Local Research Networks (CLRN) lead for the National Institute for Health Research (NIHR) network.

With his research team, Professor Macdougall has led several pivotal multicentre clinical trials that have shaped the management of renal anaemia worldwide.

As a member of the Kidney Disease Improving Global Outcomes (KDIGO) international work group, he was selected to create the latest clinical practice guideline for the management of anaemia in chronic kidney disease.

Professor Macdougall is a member of the American Society of Nephrology, the European Renal Association, the Renal Association, and the Royal Society of Medicine.